XML 80 R68.htm IDEA: XBRL DOCUMENT v3.22.4
Acquisitions - Schedule of Components and Fair Value Allocation of the Consideration Transferred in Connection with Acquisitions (Details)
€ in Millions, £ in Millions, $ in Millions
12 Months Ended
Apr. 01, 2022
USD ($)
Apr. 01, 2022
GBP (£)
Jan. 18, 2022
USD ($)
Jan. 18, 2022
EUR (€)
Nov. 17, 2021
USD ($)
Nov. 17, 2021
EUR (€)
Aug. 24, 2021
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Consideration Transferred:                      
Fair value of redeemable noncontrolling interest - other shareholders               $ 0.0 $ 0.0 $ 0.0  
Total consideration transferred               26.8 14.4    
Allocation of Consideration Transferred:                      
Goodwill               457.6 339.5 320.4 $ 293.0
BSI Nano                      
Allocation of Consideration Transferred:                      
Goodwill               292.1 238.9 $ 228.0 $ 208.5
PreOmics GmbH [Member]                      
Consideration Transferred:                      
Total consideration transferred     $ 52.1 € 46.1              
PreOmics GmbH [Member] | Bruker CALID                      
Consideration Transferred:                      
Cash paid               52.1      
Cash acquired               (16.0)      
Fair value of hybrid financial instruments - founders               20.9      
Fair value of redeemable noncontrolling interest - other shareholders               6.8      
Contingent consideration               0.0      
Working capital adjustment               0.0      
Total consideration transferred               63.8      
Allocation of Consideration Transferred:                      
Accounts receivable               0.4      
Inventories               0.6      
Other current assets               0.7      
Property, plant and equipment               1.3      
Other assets               0.4      
Goodwill               47.0      
Liabilities assumed               (7.9)      
Total consideration transferred               63.8      
PreOmics GmbH [Member] | Bruker CALID | Technology                      
Allocation of Consideration Transferred:                      
Intangible assets               12.5      
PreOmics GmbH [Member] | Bruker CALID | Customer relationships                      
Allocation of Consideration Transferred:                      
Intangible assets               6.9      
PreOmics GmbH [Member] | Bruker CALID | Backlog                      
Allocation of Consideration Transferred:                      
Intangible assets               0.0      
PreOmics GmbH [Member] | Bruker CALID | Trade name                      
Allocation of Consideration Transferred:                      
Intangible assets               1.9      
Optimal [Member]                      
Consideration Transferred:                      
Contingent consideration $ 0.4 £ 0.3                  
Optimal [Member] | Bruker BioSpin                      
Consideration Transferred:                      
Cash paid               40.3      
Cash acquired               (6.2)      
Fair value of hybrid financial instruments - founders               0.0      
Fair value of redeemable noncontrolling interest - other shareholders               0.0      
Contingent consideration               0.4      
Working capital adjustment               0.0      
Total consideration transferred               34.5      
Allocation of Consideration Transferred:                      
Accounts receivable               1.9      
Inventories               0.0      
Other current assets               0.8      
Property, plant and equipment               0.1      
Other assets               0.8      
Goodwill               18.6      
Liabilities assumed               (8.8)      
Total consideration transferred               34.5      
Optimal [Member] | Bruker BioSpin | Technology                      
Allocation of Consideration Transferred:                      
Intangible assets               5.9      
Optimal [Member] | Bruker BioSpin | Customer relationships                      
Allocation of Consideration Transferred:                      
Intangible assets               12.9      
Optimal [Member] | Bruker BioSpin | Backlog                      
Allocation of Consideration Transferred:                      
Intangible assets               1.1      
Optimal [Member] | Bruker BioSpin | Trade name                      
Allocation of Consideration Transferred:                      
Intangible assets               1.2      
Inscopix Inc [Member] | BSI Nano                      
Consideration Transferred:                      
Cash paid               101.5      
Cash acquired               (12.1)      
Fair value of hybrid financial instruments - founders               0.0      
Fair value of redeemable noncontrolling interest - other shareholders               0.0      
Contingent consideration               0.0      
Working capital adjustment               (0.6)      
Total consideration transferred               90.0      
Allocation of Consideration Transferred:                      
Accounts receivable               3.2      
Inventories               2.5      
Other current assets               0.9      
Property, plant and equipment               0.5      
Other assets               4.7      
Goodwill               52.2      
Liabilities assumed               (24.6)      
Total consideration transferred               90.0      
Inscopix Inc [Member] | BSI Nano | Technology                      
Allocation of Consideration Transferred:                      
Intangible assets               26.6      
Inscopix Inc [Member] | BSI Nano | Customer relationships                      
Allocation of Consideration Transferred:                      
Intangible assets               20.8      
Inscopix Inc [Member] | BSI Nano | Backlog                      
Allocation of Consideration Transferred:                      
Intangible assets               0.0      
Inscopix Inc [Member] | BSI Nano | Trade name                      
Allocation of Consideration Transferred:                      
Intangible assets               $ 3.2      
SCI Instruments                      
Consideration Transferred:                      
Contingent consideration             $ 1.0        
SCI Instruments | BSI Nano                      
Consideration Transferred:                      
Cash paid                 28.0    
Contingent consideration                 1.0    
Working capital adjustment                 (0.6)    
Total consideration transferred                 28.4    
Allocation of Consideration Transferred:                      
Cash                 0.0    
Accounts receivable                 0.0    
Inventories                 1.0    
Other current assets                 0.0    
Property, plant and equipment                 0.0    
Goodwill                 12.6    
Deferred taxes                 0.0    
Liabilities assumed                 (0.3)    
Total consideration transferred                 28.4    
SCI Instruments | BSI Nano | Technology                      
Allocation of Consideration Transferred:                      
Intangible assets                 7.1    
SCI Instruments | BSI Nano | Customer relationships                      
Allocation of Consideration Transferred:                      
Intangible assets                 6.4    
SCI Instruments | BSI Nano | Backlog                      
Allocation of Consideration Transferred:                      
Intangible assets                 1.2    
SCI Instruments | BSI Nano | Trade name                      
Allocation of Consideration Transferred:                      
Intangible assets                 0.4    
Molecubes NV                      
Consideration Transferred:                      
Contingent consideration         $ 0.4 € 0.4          
Total consideration transferred         $ 21.1 € 18.7          
Molecubes NV | Bruker BioSpin                      
Consideration Transferred:                      
Cash paid                 21.1    
Contingent consideration                 0.4    
Working capital adjustment                 0.0    
Total consideration transferred                 21.5    
Allocation of Consideration Transferred:                      
Cash                 1.1    
Accounts receivable                 1.2    
Inventories                 1.5    
Other current assets                 0.3    
Property, plant and equipment                 0.1    
Goodwill                 14.1    
Deferred taxes                 1.6    
Liabilities assumed                 1.6    
Total consideration transferred                 21.5    
Molecubes NV | Bruker BioSpin | Technology                      
Allocation of Consideration Transferred:                      
Intangible assets                 3.4    
Molecubes NV | Bruker BioSpin | Customer relationships                      
Allocation of Consideration Transferred:                      
Intangible assets                 2.4    
Molecubes NV | Bruker BioSpin | Backlog                      
Allocation of Consideration Transferred:                      
Intangible assets                 0.1    
Molecubes NV | Bruker BioSpin | Trade name                      
Allocation of Consideration Transferred:                      
Intangible assets                 $ 0.5